Provided by Tiger Fintech (Singapore) Pte. Ltd.

Guardant Health Inc.

50.03
+0.13000.26%
Post-market: 50.030.00000.00%18:18 EDT
Volume:2.09M
Turnover:103.65M
Market Cap:6.20B
PE:-14.81
High:50.33
Open:50.25
Low:48.07
Close:49.90
Loading ...

Guardant Health to Present Data Highlighting Advances in Multi-Cancer Detection and Liquid and Tissue Molecular Profiling at AACR

Business Wire
·
22 Apr

RXO, The Ensign Group, LifeStance Health Group, Surgery Partners, and Guardant Health Stocks Trade Down, What You Need To Know

StockStory
·
22 Apr

3 Reasons to Sell GH and 1 Stock to Buy Instead

StockStory
·
21 Apr

Bernstein Keeps Their Buy Rating on Guardant Health (GH)

TIPRANKS
·
16 Apr

Guardant Health price target raised to $60 from $56 at BofA

TipRanks
·
15 Apr

S&P 500 Futures Up In Premarket Trading; Guardant Health, Brookfield Wealth Solns Lead

Dow Jones
·
11 Apr

Press Release: Guardant Health to Report First Quarter 2025 Financial Results on April 30, 2025

Dow Jones
·
11 Apr

Guardant Health Is Maintained at Overweight by Barclays

Dow Jones
·
10 Apr

Guardant Health price target lowered to $55 from $60 at Barclays

TIPRANKS
·
10 Apr

Guardant Health: Poised for Growth with Innovative Precision Oncology Solutions

TIPRANKS
·
10 Apr

BRIEF-Guardant Health And Bayshore Healthcare Partner To Expand Access To Advanced Precision Oncology Testing In Canada

Reuters
·
03 Apr

Guardant Health and Bayshore Healthcare Partner to Expand Access to Advanced Precision Oncology Testing in Canada

THOMSON REUTERS
·
03 Apr

Guardant Health and Bayshore HealthCare Partner to Expand Access to Advanced Precision Oncology Testing in Canada

Business Wire
·
03 Apr

3 Small-Cap Stocks in the Doghouse

StockStory
·
01 Apr

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Zacks
·
01 Apr

Crinetics Pharmaceuticals Announces European Medicines Agency (EMA) Validation of Marketing Authorization Application (MAA) and Orphan Drug Designation (ODD) for Paltusotine in Acromegaly

GlobeNewswire
·
28 Mar

Craig-Hallum Sticks to Its Buy Rating for Guardant Health (GH)

TIPRANKS
·
26 Mar

Guardant Health Price Target Maintained With a $55.00/Share by Stephens & Co.

Dow Jones
·
26 Mar

Guardant Health’s Shield Blood Test Now Covered for VA Community Care Beneficiaries

Business Wire
·
26 Mar

1 Healthcare Stock on Our Watchlist and 2 to Turn Down

StockStory
·
20 Mar